Drug Trial Radar · NCT02194738
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
7,458
Actual
Start
Sep 26, 2014
Primary completion
Dec 3, 2025
Study completion Sep 21, 2027
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Jul 18, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Conditions
- Stage IB Lung Non-Small Cell Carcinoma AJCC v7
- Stage II Lung Non-Small Cell Cancer AJCC v7
- Stage IIA Lung Cancer AJCC v8
- Stage IIB Lung Cancer AJCC v8
- Stage IIIA Lung Cancer AJCC v8
- Stage IIIA Lung Non-Small Cell Cancer AJCC v7
- Stage IIIB Lung Cancer AJCC v8
Interventions
Biospecimen CollectionProcedure
Undergo collection of blood samples
CarboplatinDrug
Given IV
CisplatinDrug
Given IV
Clinical ObservationOther
Undergo observation
Computed TomographyProcedure
Undergo CT or PET/CT
CrizotinibDrug
Given PO
Cytology Specimen Collection ProcedureOther
Undergo collection of blood and tissue
Echocardiography TestProcedure
Undergo ECHO
ErlotinibDrug
Given PO
Gemcitabine HydrochlorideDrug
Given IV
NivolumabBiological
Given IV
PaclitaxelDrug
Given IV
PembrolizumabBiological
Given IV
PemetrexedDrug
Given IV
Pemetrexed DisodiumDrug
Given IV
Placebo AdministrationOther
Given PO
Positron Emission TomographyProcedure
Undergo PET/CT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Central and local clinical genotyping to facilitate accrual to the adjuvant Intergroup studies, E4512 and A081105Time frame: Up to 4 years
- Feasibility of research grade formalin-fixed, paraffin-embedded tissue collection for Center for Cancer Genomics (CCG) analysisTime frame: Up to 4 years
Locations
1,660 sites in 3 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Southern Cancer Center PC-Daphne
Daphne, Alabama
Southern Cancer Center PC-Mobile
Mobile, Alabama
Southern Cancer Center PC-Providence
Mobile, Alabama
Southern Cancer Center PC-Springhill
Mobile, Alabama
Anchorage Associates in Radiation Medicine
Anchorage, Alaska
Anchorage Radiation Therapy Center
Anchorage, Alaska
Alaska Breast Care and Surgery LLC
Anchorage, Alaska
Alaska Oncology and Hematology LLC
Anchorage, Alaska
Alaska Regional Hospital
Anchorage, Alaska
Alaska Women's Cancer Care
Anchorage, Alaska
Anchorage Oncology Centre
Anchorage, Alaska
Katmai Oncology Group
Anchorage, Alaska
Providence Alaska Medical Center
Anchorage, Alaska
Fairbanks Memorial Hospital
Fairbanks, Alaska
Banner MD Anderson Cancer Center
Gilbert, Arizona
Kingman Regional Medical Center
Kingman, Arizona
Cancer Center at Saint Joseph's
Phoenix, Arizona
Banner-University Medical Center Phoenix
Phoenix, Arizona
Mayo Clinic Hospital in Arizona
Phoenix, Arizona
Mayo Clinic in Arizona
Scottsdale, Arizona
Banner Boswell Medical Center
Sun City, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
University of Arizona Cancer Center-North Campus
Tucson, Arizona
Mercy Hospital Fort Smith
Fort Smith, Arkansas
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas
NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas
CARTI Cancer Center
Little Rock, Arkansas
John L McClellan Memorial Veterans Hospital
Little Rock, Arkansas
Kaiser Permanente-Anaheim
Anaheim, California
Kaiser Permanente-Deer Valley Medical Center
Antioch, California
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California
PCR Oncology
Arroyo Grande, California
Sutter Auburn Faith Hospital
Auburn, California
Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California
AIS Cancer Center at San Joaquin Community Hospital
Bakersfield, California
Kaiser Permanente-Baldwin Park
Baldwin Park, California
Kaiser Permanente-Bellflower
Bellflower, California
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Keck Medicine of USC Buena Park
Buena Park, California
Showing 40 of 1,660 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.